Agent for treating high-risk impaired glucose tolerance

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 6200958
SERIAL NO

09347028

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention discloses an .alpha.-glucosidase inhibitor for prevention of transition from high-risk IGT to diabetes mellitus, for prophylaxis of diabetes mellitus, as well as for treating high-risk IGT.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
TAKEDA PHARMACEUTICAL COMPANY LIMITED1-1 DOSHOMACHI 4-CHOME CHUO-KU OSAKA-SHI OSAKA 541-0045

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Nakaoka, Ichiro Hirakata, JP 2 45
Odaka, Hiroyuki Kobe, JP 71 658
Suzuki, Yoshiharu Suita, JP 53 828

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation